Common Stock, Shares, Issued of Ambrx Biopharma Cayman, Inc. from 31 Dec 2020 to 30 Jun 2023

Taxonomy & unit: us-gaap: shares
Description: Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary: Ambrx Biopharma Cayman, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 31 Dec 2020 to 30 Jun 2023.
Ambrx Biopharma Cayman, Inc. Common Stock, Shares, Issued for the quarter ending 30 Jun 2023 was 432,227,488, a 60% increase year-over-year.
Source SEC data: View on sec.gov

Common Stock, Shares, Issued, Quarterly (shares)

Common Stock, Shares, Issued, YoY Quarterly Change (%)

Ambrx Biopharma Cayman, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2023	432,227,488	+161,899,005	+60%	30 Jun 2023	10-Q	09 Aug 2023	2023	Q2
Q1 2023	386,486,014			31 Mar 2023	10-Q	11 May 2023	2023	Q1
Q4 2022	270,455,232	+334,684	+0.12%	31 Dec 2022	10-Q	09 Aug 2023	2023	Q2
Q2 2022	270,328,483			30 Jun 2022	6-K	29 Aug 2022	2022	Q2
Q4 2021	270,120,548	+269,950,548	+158794%	31 Dec 2021	10-K	30 Mar 2023	2022	FY
Q4 2020	170,000^*			31 Dec 2020	20-F	26 Apr 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.